HEADER TRANSFERASE 29-JUL-23 8Q0U TITLE IDENTIFICATION AND OPTIMISATION OF NOVEL INHIBITORS OF THE POLYKETIDE TITLE 2 SYNTHETASE 13 THIOESTERASE DOMAIN WITH ANTITUBERCULAR ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYKETIDE SYNTHASE PKS13; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.3.1.-; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: PKS13, RV3800C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.C.EADSFORTH,A.S.PUNEKAR,S.R.GREEN,B.BARAGANA REVDAT 2 06-DEC-23 8Q0U 1 JRNL REVDAT 1 22-NOV-23 8Q0U 0 JRNL AUTH S.R.GREEN,C.WILSON,T.C.EADSFORTH,A.S.PUNEKAR,F.K.TAMAKI, JRNL AUTH 2 G.WOOD,N.CALDWELL,B.FORTE,N.R.NORCROSS,M.KICZUN,J.M.POST, JRNL AUTH 3 E.M.LOPEZ-ROMAN,C.A.ENGELHART,I.LUKAC,F.ZUCCOTTO,O.EPEMOLU, JRNL AUTH 4 H.I.M.BOSHOFF,D.SCHNAPPINGER,C.WALPOLE,I.H.GILBERT,K.D.READ, JRNL AUTH 5 P.G.WYATT,B.BARAGANA JRNL TITL IDENTIFICATION AND OPTIMIZATION OF NOVEL INHIBITORS OF THE JRNL TITL 2 POLYKETIDE SYNTHASE 13 THIOESTERASE DOMAIN WITH JRNL TITL 3 ANTITUBERCULAR ACTIVITY. JRNL REF J.MED.CHEM. V. 66 15380 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37948640 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01514 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 68.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 45754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2430 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3565 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 195 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4298 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 412 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.49000 REMARK 3 B22 (A**2) : -1.00000 REMARK 3 B33 (A**2) : 0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.152 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.143 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.891 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4506 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4129 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6121 ; 1.860 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9529 ; 1.059 ; 2.985 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 553 ; 6.061 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 226 ;30.966 ;22.965 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 704 ;14.280 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;20.236 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 645 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5105 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 956 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2212 ; 2.679 ; 2.782 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2211 ; 2.676 ; 2.780 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2765 ; 3.702 ; 4.151 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2766 ; 3.703 ; 4.153 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2294 ; 3.533 ; 3.225 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2286 ; 3.526 ; 3.208 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3340 ; 5.339 ; 4.664 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5261 ; 7.361 ;34.703 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5158 ; 7.242 ;34.293 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8Q0U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292132353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9159 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48490 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 68.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH 8.5, 1.8 M AMMONIUM REMARK 280 SULFATE, 3% PPG400, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 43.78250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.30300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.78250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.30300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1448 REMARK 465 ASN A 1449 REMARK 465 ALA A 1450 REMARK 465 SER A 1728 REMARK 465 GLU A 1729 REMARK 465 VAL A 1730 REMARK 465 GLY A 1731 REMARK 465 LYS A 1732 REMARK 465 GLN A 1733 REMARK 465 SER B 1448 REMARK 465 ASN B 1449 REMARK 465 ALA B 1450 REMARK 465 PHE B 1590 REMARK 465 ASN B 1591 REMARK 465 VAL B 1592 REMARK 465 THR B 1593 REMARK 465 SER B 1728 REMARK 465 GLU B 1729 REMARK 465 VAL B 1730 REMARK 465 GLY B 1731 REMARK 465 LYS B 1732 REMARK 465 GLN B 1733 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1600 CG CD OE1 OE2 REMARK 470 GLN A1647 CG CD OE1 NE2 REMARK 470 THR A1727 OG1 CG2 REMARK 470 GLU B1600 CG CD OE1 OE2 REMARK 470 GLN B1647 CG CD OE1 NE2 REMARK 470 MET B1669 CG SD CE REMARK 470 THR B1727 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A1460 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A1502 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ASP A1652 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ARG A1717 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A1726 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A1726 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B1460 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES REMARK 500 ARG B1460 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG B1547 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG B1547 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG B1554 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG B1612 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG B1634 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1533 -131.51 61.78 REMARK 500 GLN A1570 70.35 -102.19 REMARK 500 GLU B1464 -31.19 -38.47 REMARK 500 SER B1533 -129.97 62.34 REMARK 500 GLN B1570 62.46 -100.26 REMARK 500 PRO B1598 107.50 -59.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2088 DISTANCE = 6.59 ANGSTROMS DBREF 8Q0U A 1451 1733 UNP I6X8D2 PKS13_MYCTU 1451 1733 DBREF 8Q0U B 1451 1733 UNP I6X8D2 PKS13_MYCTU 1451 1733 SEQADV 8Q0U SER A 1448 UNP I6X8D2 EXPRESSION TAG SEQADV 8Q0U ASN A 1449 UNP I6X8D2 EXPRESSION TAG SEQADV 8Q0U ALA A 1450 UNP I6X8D2 EXPRESSION TAG SEQADV 8Q0U SER B 1448 UNP I6X8D2 EXPRESSION TAG SEQADV 8Q0U ASN B 1449 UNP I6X8D2 EXPRESSION TAG SEQADV 8Q0U ALA B 1450 UNP I6X8D2 EXPRESSION TAG SEQRES 1 A 286 SER ASN ALA GLN ILE ASP GLY PHE VAL ARG THR LEU ARG SEQRES 2 A 286 ALA ARG PRO GLU ALA GLY GLY LYS VAL PRO VAL PHE VAL SEQRES 3 A 286 PHE HIS PRO ALA GLY GLY SER THR VAL VAL TYR GLU PRO SEQRES 4 A 286 LEU LEU GLY ARG LEU PRO ALA ASP THR PRO MET TYR GLY SEQRES 5 A 286 PHE GLU ARG VAL GLU GLY SER ILE GLU GLU ARG ALA GLN SEQRES 6 A 286 GLN TYR VAL PRO LYS LEU ILE GLU MET GLN GLY ASP GLY SEQRES 7 A 286 PRO TYR VAL LEU VAL GLY TRP SER LEU GLY GLY VAL LEU SEQRES 8 A 286 ALA TYR ALA CYS ALA ILE GLY LEU ARG ARG LEU GLY LYS SEQRES 9 A 286 ASP VAL ARG PHE VAL GLY LEU ILE ASP ALA VAL ARG ALA SEQRES 10 A 286 GLY GLU GLU ILE PRO GLN THR LYS GLU GLU ILE ARG LYS SEQRES 11 A 286 ARG TRP ASP ARG TYR ALA ALA PHE ALA GLU LYS THR PHE SEQRES 12 A 286 ASN VAL THR ILE PRO ALA ILE PRO TYR GLU GLN LEU GLU SEQRES 13 A 286 GLU LEU ASP ASP GLU GLY GLN VAL ARG PHE VAL LEU ASP SEQRES 14 A 286 ALA VAL SER GLN SER GLY VAL GLN ILE PRO ALA GLY ILE SEQRES 15 A 286 ILE GLU HIS GLN ARG THR SER TYR LEU ASP ASN ARG ALA SEQRES 16 A 286 ILE ASP THR ALA GLN ILE GLN PRO TYR ASP GLY HIS VAL SEQRES 17 A 286 THR LEU TYR MET ALA ASP ARG TYR HIS ASP ASP ALA ILE SEQRES 18 A 286 MET PHE GLU PRO ARG TYR ALA VAL ARG GLN PRO ASP GLY SEQRES 19 A 286 GLY TRP GLY GLU TYR VAL SER ASP LEU GLU VAL VAL PRO SEQRES 20 A 286 ILE GLY GLY GLU HIS ILE GLN ALA ILE ASP GLU PRO ILE SEQRES 21 A 286 ILE ALA LYS VAL GLY GLU HIS MET SER ARG ALA LEU GLY SEQRES 22 A 286 GLN ILE GLU ALA ASP ARG THR SER GLU VAL GLY LYS GLN SEQRES 1 B 286 SER ASN ALA GLN ILE ASP GLY PHE VAL ARG THR LEU ARG SEQRES 2 B 286 ALA ARG PRO GLU ALA GLY GLY LYS VAL PRO VAL PHE VAL SEQRES 3 B 286 PHE HIS PRO ALA GLY GLY SER THR VAL VAL TYR GLU PRO SEQRES 4 B 286 LEU LEU GLY ARG LEU PRO ALA ASP THR PRO MET TYR GLY SEQRES 5 B 286 PHE GLU ARG VAL GLU GLY SER ILE GLU GLU ARG ALA GLN SEQRES 6 B 286 GLN TYR VAL PRO LYS LEU ILE GLU MET GLN GLY ASP GLY SEQRES 7 B 286 PRO TYR VAL LEU VAL GLY TRP SER LEU GLY GLY VAL LEU SEQRES 8 B 286 ALA TYR ALA CYS ALA ILE GLY LEU ARG ARG LEU GLY LYS SEQRES 9 B 286 ASP VAL ARG PHE VAL GLY LEU ILE ASP ALA VAL ARG ALA SEQRES 10 B 286 GLY GLU GLU ILE PRO GLN THR LYS GLU GLU ILE ARG LYS SEQRES 11 B 286 ARG TRP ASP ARG TYR ALA ALA PHE ALA GLU LYS THR PHE SEQRES 12 B 286 ASN VAL THR ILE PRO ALA ILE PRO TYR GLU GLN LEU GLU SEQRES 13 B 286 GLU LEU ASP ASP GLU GLY GLN VAL ARG PHE VAL LEU ASP SEQRES 14 B 286 ALA VAL SER GLN SER GLY VAL GLN ILE PRO ALA GLY ILE SEQRES 15 B 286 ILE GLU HIS GLN ARG THR SER TYR LEU ASP ASN ARG ALA SEQRES 16 B 286 ILE ASP THR ALA GLN ILE GLN PRO TYR ASP GLY HIS VAL SEQRES 17 B 286 THR LEU TYR MET ALA ASP ARG TYR HIS ASP ASP ALA ILE SEQRES 18 B 286 MET PHE GLU PRO ARG TYR ALA VAL ARG GLN PRO ASP GLY SEQRES 19 B 286 GLY TRP GLY GLU TYR VAL SER ASP LEU GLU VAL VAL PRO SEQRES 20 B 286 ILE GLY GLY GLU HIS ILE GLN ALA ILE ASP GLU PRO ILE SEQRES 21 B 286 ILE ALA LYS VAL GLY GLU HIS MET SER ARG ALA LEU GLY SEQRES 22 B 286 GLN ILE GLU ALA ASP ARG THR SER GLU VAL GLY LYS GLN HET SO4 A1801 5 HET IKG A1802 34 HET SO4 B1801 5 HET IKG B1802 34 HETNAM SO4 SULFATE ION HETNAM IKG ~{N}-[(1~{R})-2-[4-(AZETIDIN-1-YLCARBONYL)PHENYL]-1- HETNAM 2 IKG CYANO-ETHYL]-3-(3,4-DIMETHOXYPHENYL)-1,2,4-OXADIAZOLE- HETNAM 3 IKG 5-CARBOXAMIDE HETSYN IKG ACV THIOALDEHYDE FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 IKG 2(C24 H23 N5 O5) FORMUL 7 HOH *412(H2 O) HELIX 1 AA1 SER A 1480 VAL A 1483 5 4 HELIX 2 AA2 TYR A 1484 ARG A 1490 1 7 HELIX 3 AA3 SER A 1506 GLY A 1523 1 18 HELIX 4 AA4 SER A 1533 LEU A 1549 1 17 HELIX 5 AA5 THR A 1571 ASN A 1591 1 21 HELIX 6 AA6 PRO A 1598 GLU A 1604 1 7 HELIX 7 AA7 ASP A 1606 SER A 1619 1 14 HELIX 8 AA8 PRO A 1626 ILE A 1643 1 18 HELIX 9 AA9 HIS A 1664 GLU A 1671 1 8 HELIX 10 AB1 PRO A 1672 VAL A 1676 5 5 HELIX 11 AB2 GLU A 1698 ALA A 1702 5 5 HELIX 12 AB3 ILE A 1707 THR A 1727 1 21 HELIX 13 AB4 SER B 1480 VAL B 1483 5 4 HELIX 14 AB5 TYR B 1484 ARG B 1490 1 7 HELIX 15 AB6 SER B 1506 GLY B 1523 1 18 HELIX 16 AB7 SER B 1533 LEU B 1549 1 17 HELIX 17 AB8 THR B 1571 THR B 1589 1 19 HELIX 18 AB9 PRO B 1598 GLU B 1603 1 6 HELIX 19 AC1 ASP B 1606 SER B 1621 1 16 HELIX 20 AC2 PRO B 1626 ILE B 1643 1 18 HELIX 21 AC3 ASP B 1644 ALA B 1646 5 3 HELIX 22 AC4 HIS B 1664 GLU B 1671 1 8 HELIX 23 AC5 PRO B 1672 VAL B 1676 5 5 HELIX 24 AC6 GLU B 1698 ALA B 1702 5 5 HELIX 25 AC7 PRO B 1706 ASP B 1725 1 20 SHEET 1 AA1 8 ILE A1452 ASP A1453 0 SHEET 2 AA1 8 VAL A1456 ARG A1460 -1 O VAL A1456 N ASP A1453 SHEET 3 AA1 8 MET A1497 PHE A1500 -1 O GLY A1499 N ARG A1457 SHEET 4 AA1 8 VAL A1471 PHE A1474 1 N VAL A1473 O PHE A1500 SHEET 5 AA1 8 TYR A1527 TRP A1532 1 O VAL A1530 N PHE A1472 SHEET 6 AA1 8 VAL A1553 ILE A1559 1 O ILE A1559 N GLY A1531 SHEET 7 AA1 8 VAL A1655 MET A1659 1 O THR A1656 N VAL A1556 SHEET 8 AA1 8 LEU A1690 PRO A1694 1 O GLU A1691 N LEU A1657 SHEET 1 AA2 8 ILE B1452 ASP B1453 0 SHEET 2 AA2 8 VAL B1456 ARG B1460 -1 O VAL B1456 N ASP B1453 SHEET 3 AA2 8 MET B1497 PHE B1500 -1 O GLY B1499 N ARG B1457 SHEET 4 AA2 8 VAL B1471 PHE B1474 1 N VAL B1473 O PHE B1500 SHEET 5 AA2 8 TYR B1527 TRP B1532 1 O VAL B1530 N PHE B1472 SHEET 6 AA2 8 VAL B1553 ILE B1559 1 O GLY B1557 N GLY B1531 SHEET 7 AA2 8 VAL B1655 MET B1659 1 O THR B1656 N LEU B1558 SHEET 8 AA2 8 LEU B1690 PRO B1694 1 O GLU B1691 N LEU B1657 CISPEP 1 GLY A 1525 PRO A 1526 0 -2.92 CISPEP 2 GLU A 1705 PRO A 1706 0 3.91 CISPEP 3 GLU B 1705 PRO B 1706 0 -1.29 CRYST1 87.565 108.606 57.525 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011420 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017384 0.00000